Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Scleroderma in children and adolescents.

Kevin J Murray1, Ronald M Laxer

  • 1Department of Rheumatology, Princess Margaret Hospital for Children, GPO Box D184, Perth, WA 6008, Australia. jmangharam@hotmail.com

Rheumatic Diseases Clinics of North America
|October 17, 2002
PubMed
Summary

Scleroderma disorders in children are complex. Understanding their unique causes and developing standardized clinical trials are crucial for advancing pediatric rheumatology care and treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical Roflumilast for Pediatric Morphea.

Journal of cutaneous medicine and surgery·2026
Same author

Baricitinib in two paediatric patients with coatomer subunit alpha (COPA) syndrome: A case series and literature review.

Modern rheumatology case reports·2026
Same author

Pediatric morphea: MRI evaluation of superficial and deep tissue involvement and impact in clinical practice.

Pediatric radiology·2026
Same author

Differentiating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) and Syndrome of Undifferentiated Recurrent Fever (SURF): A Comparative Study of Clinical Features, Treatment Response, and Remission.

The Journal of rheumatology·2026
Same author

Intravenous immunoglobulin for the treatment of morphea in pediatric patients: A case series.

JAAD case reports·2026
Same author

Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic Arthritis.

The Journal of rheumatology·2025

Area of Science:

  • Pediatric rheumatology
  • Immunopathology
  • Dermatology

Background:

  • Scleroderma disorders present significant challenges in pediatric rheumatology for both pathological understanding and clinical management.
  • Current understanding of localized scleroderma (LS) lesions suggests potential unique immunopathogenic mechanisms or patient-specific genetic factors.
  • Advances in rheumatology therapies necessitate the development of robust clinical trials for these conditions.

Purpose of the Study:

  • To highlight the complexity of pediatric scleroderma disorders.
  • To emphasize the need for research into unique immunopathogenic mechanisms and patient characteristics.
  • To advocate for the development of controlled clinical trials with standardized outcome measures.

Main Methods:

  • Review of current understanding of scleroderma pathobiology.
  • Analysis of potential etiological factors in localized scleroderma.
  • Discussion of clinical trial design requirements.

Main Results:

  • Scleroderma disorders are challenging in pediatric rheumatology.
  • Localized scleroderma lesions may arise from distinct immunopathogenic pathways or patient-specific factors.
  • Progress in clinical approaches is evident, but further research is needed.

Conclusions:

  • Further investigation into the distinct mechanisms underlying scleroderma lesions is warranted.
  • Development of controlled clinical trials with agreed-upon outcome measures is critical for both localized and systemic pediatric scleroderma.
  • Advancements in pediatric rheumatology care depend on rigorous clinical research and therapeutic innovation.

Related Experiment Videos